SRZN
Surrozen Inc
NASDAQ: SRZN · HEALTHCARE · BIOTECHNOLOGY
$31.56
+1.87% today
Updated 2026-04-29
Market cap
$371.23M
P/E ratio
—
P/S ratio
106.77x
EPS (TTM)
$-32.37
Dividend yield
—
52W range
$6 – $34
Volume
0.1M
Surrozen Inc (SRZN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $42.48M | $62.06M | $137.17M | $89.44M | $46.08M | $48.47M |
| Cash & equivalents | $29.10M | $34.98M | $33.09M | $24.69M | $36.04M | $34.56M |
| Current assets | $29.41M | $50.22M | $105.19M | $81.31M | $41.13M | $38.93M |
| Total liabilities | $13.10M | $14.77M | $27.47M | $13.43M | $8.14M | $69.85M |
| Current liabilities | $3.90M | $7.28M | $13.57M | $9.73M | $7.15M | $7.32M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $29.39M | $47.29M | $109.70M | $76.00M | $37.94M | $-21.38M |
| Retained earnings | $-55.28M | $-88.00M | $-142.65M | $-178.65M | $-221.69M | $-285.26M |
| Accounts receivable | — | — | $0.00 | $1.98M | $2.15M | $2.54M |
| Inventory | — | — | — | — | $1.00 | — |
| Goodwill | — | — | — | — | — | — |